Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature
- PMID: 7202083
- DOI: 10.1016/0022-4731(82)90038-3
Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature
Abstract
A mathematical model for the calculation of free and protein bound concentrations of testosterone and estradiol in plasma is presented. The method is based on the knowledge of the total concentrations of all steroids competing for the same binding site on testosterone-estradiol-binding globulin (TeBG), the concentration of albumin, the binding capacity of TeBG, and the association constants of the steroids to the two binding proteins. For the calculations we have determined the total concentrations of testosterone and estradiol. TeBG binding capacity, albumin concentration and the association constants for the binding of testosterone, estradiol and 5 alpha-dihydrotestosterone (DHT) to TeBG and albumin at 37 degrees C. Physiological concentrations of some androgen metabolites reported in the literature were also included in the calculations, namely: DHT, 5-androstene-3 beta, 17 beta-diol (Ae) and 5 alpha-androstane-3 alpha, 17 beta-diol (Aa). The binding constants for Ae and Aa to TeBG and albumin were also from the literature. Mean values of testosterone were calculated for 11 normal men and expressed as percentages of total: 2.0% was unbound, 53--55% bound to albumin and 43--45% bound to TeBG. For 16 normal women of a fertile age the corresponding values were 1.5%, 36--37% and 62%. For estradiol they were 2.4% 68--70% and 28--30% in the men and 2.0%, 52% and 45--46% in the women. Variations in the concentrations of DHT. Ae and Aa did not influence the free concentrations of testosterone and estradiol to any significant extent. It was furthermore concluded that the androgen metabolites could be omitted from the calculations without affecting the calculated concentrations.
Similar articles
-
Measurement of the testosterone binding parameters for both testosterone-estradiol binding globulin and albumin in individual serum samples.Steroids. 1979 Dec;34(7):771-91. doi: 10.1016/0039-128x(79)90090-4. Steroids. 1979. PMID: 575443
-
The temperature dependence of the binding of 5 alpha-dihydrotestosterone, testosterone and estradiol to the sex hormone globulin (SHBG) of human plasma.J Steroid Biochem. 1986 Feb;24(2):549-55. doi: 10.1016/0022-4731(86)90118-4. J Steroid Biochem. 1986. PMID: 3702439
-
Steroid-binding proteins in rabbit plasma: Separation of testosterone-binding globulin (TeBG) from corticosteroid-binding globulin (CBG), preliminary characterization of TeBG, and changes in TeBG concentration during sexual maturation.Mol Cell Endocrinol. 1975 May;2(5):351-68. doi: 10.1016/0303-7207(75)90022-2. Mol Cell Endocrinol. 1975. PMID: 47821
-
Serum bioavailability of sex steroid hormones.Clin Endocrinol Metab. 1986 May;15(2):259-78. doi: 10.1016/s0300-595x(86)80024-x. Clin Endocrinol Metab. 1986. PMID: 3521955 Review.
-
Reflections concerning biochemical parameters of androgenicity.Aging Male. 2004 Dec;7(4):280-9. doi: 10.1080/13685530400016615. Aging Male. 2004. PMID: 15799123 Review.
Cited by
-
Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women.Cancer Causes Control. 2013 Jun;24(6):1087-97. doi: 10.1007/s10552-013-0186-0. Epub 2013 Mar 21. Cancer Causes Control. 2013. PMID: 23515936 Free PMC article.
-
SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer.Osteoporos Int. 2013 Feb;24(2):713-9. doi: 10.1007/s00198-012-2012-z. Epub 2012 May 16. Osteoporos Int. 2013. PMID: 22588185
-
Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels.J Bone Miner Metab. 2014 Jan;32(1):65-70. doi: 10.1007/s00774-013-0466-5. Epub 2013 May 3. J Bone Miner Metab. 2014. PMID: 23640678
-
Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women.Breast Cancer Res. 2012 Oct 31;14(5):R141. doi: 10.1186/bcr3346. Breast Cancer Res. 2012. PMID: 23113944 Free PMC article.
-
The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program.Metabolism. 2013 Sep;62(9):1313-22. doi: 10.1016/j.metabol.2013.04.005. Epub 2013 May 6. Metabolism. 2013. PMID: 23660512 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources